Glenmark Pharmaceuticals’s consolidated net profit clocks in growth of 23% in Q1

26 Jul 2011 Evaluate

Glenmark Pharmaceuticals has reported results for the quarter ended June 30, 2011.

The company‘s net profit has registered growth of 19.20% at Rs 72.46 crore for the quarter as compared to Rs 60.79 crore for the corresponding quarter of the previous year. Its total income has increased by 19.14% at Rs 330.78 crore for the Q1FY12 from Rs 277.62 crore for the Q1FY11.

On consolidated basis, the group’s net profit for the quarter ended June 30, 2011 has clocked in 23.20% growth at Rs 210.11 crore as compared to Rs 170.54 crore for the June quarter of the previous fiscal. Its total income has increased by 26.77% to Rs 880.80 crore for the quarter from Rs 694.81 crore for the June quarter of FY11.

Glenmark Pharma Share Price

2037.85 8.25 (0.41%)
31-Dec-2025 14:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1270.50
Cipla 1508.15
Zydus Lifesciences 913.00
Lupin 2111.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×